210 likes | 335 Vues
Recent registry data offers valuable insights into the performance and outcomes of Drug-Eluting Stents (DES) versus Bare Metal Stents (BMS). This analysis explores critical factors such as safety profiles, patient outcomes, revascularization rates, and long-term efficacy. Understanding these differences is essential for healthcare professionals to make informed decisions when selecting stent types for patients with coronary artery disease. The study underscores the importance of personalized treatment approaches based on patient-specific characteristics and clinical scenarios.
E N D